Skip to main content
 CHANGE IN VISITATION GUIDELINES: Please read before visiting Rutgers Cancer Institute.

ScreenNJ — Colorectal & Lung Cancer Prevention, Education, and Screening

ScreenNJ logoIn partnership with the Rutgers Cancer Institute of New Jersey, the New Jersey Department of Health, and healthcare and community organizations across New Jersey, ScreenNJ aims to increase screening for colorectal and lung cancer, to reduce cancer mortality rates, to reduce disparities, and to educate New Jersey residents about the importance of cancer screening, early detection, and prevention. ScreenNJ was launched in 2017 and is funded in part by the State.

The initial focus of ScreenNJ is on colorectal cancer and lung cancer, which are among the most prevalent cancers in the state. These cancers have better outcomes if detected early through proven screening methods such as low-dose computerized tomography (LDCT) scans for lung cancer and colonoscopy, FIT, and other recommended tests for colorectal cancer.

The goals of ScreenNJ are to:

  • increase screening rates for colorectal and lung cancer,
  • support smoking cessation to reduce cancer risk,
  • reduce colorectal and lung cancer mortality rates,
  • address and reduce disparities in smoking, screening, and mortality rates in colorectal and lung cancer, and
  • increase awareness for NJ residents and providers about the importance of colorectal and lung cancer screening, early detection, and prevention.

To learn more about ScreenNJ and to access cancer screening services, visit us at and follow us on Facebook and Twitter.

Partnership Opportunities

ScreenNJ partners with and supports healthcare provider agencies, public health agencies, and community organizations throughout the state that provide education on, refer patients to, or directly provide screening services for colorectal cancer and/or lung cancer.

There are many ways to partner with ScreenNJ – including coordinating community outreach events, sharing resources, participating in healthcare provider continuing education, contributing innovative ideas and best practices, and receiving funding to support clinical practice improvements and other activities to improve screening rates.

Learn more at